Inheritance of pulmonary adenoma susceptibility in mice

Progress in Experimental Tumor Research

Volumn 35, Issue , 1999, Pages 78-94

  Malkinson, Alvin M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ANIMAL; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; LUNG TUMOR; MOUSE; MOUSE STRAIN; REVIEW;

ADENOMA; ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED STRAINS;

EID: 0032612604     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000062005     Document Type: Article

References (95)

1. Strong LC: Inbred mice in science; in Morse HC (ed): Origins of Inbred Mice. New York, Academic Press, 1978, pp 45-68.
2. Malkinson AM, Beer DS: A single gene in BALB/cBy mice with a major effect on susceptibility to urethane-induced pulmonary adenoma. J Natl Cancer Inst 1983;70:931-936.
3. Lynch CJ: Studies on the relation between tumor susceptibility and heredity. III. Spontaneous tumors of the lung in mice. J Exp Med 1926;43:339-355.
4. Andervont HB: Pulmonary tumors in mice. V. Further studies on the influence of heredity upon spontaneous and induced lung tumors. Public Health Rep 1938;53:135-145.
5. Murphy JB, Sturm E: Primary lung tumors in mice following cutaneous application of coal tar. J Exp Med 1925;42:693-700.
6. Heston WE: Genetic analysis of susceptibility to induced pulmonary tumors in mice. J Natl Cancer Inst 1942;3:69-78.
7. Den Engelse L, Oomen LC, Van Der Valk MA, Hart AA, Dux A, Emmelot P: Studies on lung tumours. V. Susceptibility of mice to dimethylnitrosamine-induced tumour formation in relation to H-2 haplotype. Int J Cancer 1981;28:199.
8. Miyashita N, Moriwaki K: H-2-controlled genetic susceptibility to pulmonary adenomas induced by urethane and 4-nitroquinoline 1-oxide in A/Wy congenic strains. Jpn J Cancer Res 1987;78:494-498.
9. Thompson JA, Schullek KM, Fernandez CA, Malkinson AM: A metabolite of butylated hydroxytoluene with potent tumor promoting activity in mouse lung. Carcinogenesis 1989;10:773-775.
10. Obata M, Mishimuri H, Ogawa K, Lee G-H: Identification of the Par2 (pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene 1996;13:1599-1604.
11. Manenti G, Gariboldi M, Fiorino A, Zedda AI, Pierotti MA, Dragani T: Par1 is a common lung cancer susceptibility locus in three mouse strains. Mamm Genome 1997;8:801-804.
12. Malkinson AM, Nesbitt MN, Skamene E: Susceptibility to urethan-induced pulmonary adenomas between A/J and C57BL/6J mice: Use of AXB and BXA recombinant inbred lines indicating a three-locus genetic model. J Natl Cancer Inst 1985;7:971-974.
13. Malkinson AM, Beer DS: Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation. J Natl Cancer Inst 1984;73:925-933.
14. Malkinson AM: The genetic basis of susceptibility to lung tumors in mice. Toxicology 1989;54:241-271.
15. Dragani TA, Manenti G, Pierotti MA: Genetics of mouse lung tumors. Adv Cancer Res 1995;87:83-112.
16. Ryan J, Baker PE, Nesbitt MN, Ruddle FH: KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J Natl Cancer Inst 1987;79:1351-1357.
17. You M, Candrian U, Maronpot RR, Stoner GD, Anderson MW: Activation of the Ki-ra5 protooncogene in spontaneously occurring and chemically-induced lung tumors of the strain A mouse. Proc Natl Acad Sci USA 1989;86:3070-3074.
18. Bos JL: Ras oncogenes in human cancer: A review. Cancer Res 1989;40:4682-4689.
19. Belinsky SA, Devereux TR, Foley JF, White CM, Maronpot RR, Anderson MW: The role of alveolar type 2 cells in the development and progression of pulmonary tumors in the A/J mouse. Cancer Res 1992;52:3164-3173.
20. Stanley L: Molecular aspects of chemical carcinogenesis - The role of oncogenes and tumor suppressor genes. Toxicology 1995;96:175-194.
21. Horio Y, Schrump DS, Chen A, Rice P, Malkinson AK, Roth JA: Kras and p53 mutations are early and late events, respectively, in urethane induced pulmonary carcinogenesis. Mol Carcinog 1996;17:217-223.
22. Ichikawa T, Yano Y, Ochida M, Otani S, Hagiwara K, Yano T: The activation of the Kras gene at an early stage of lung tumorigenesis in mice. Cancer Lett 1996;107:165-170.
23. You M, Wang Y, Stoner G, You L, Maronpot R, Reynolds SH, Anderson M: Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc Natl Acad Sci USA 1992;89:5804-5808.
24. Massey TE, Devereux TR, Maronpot RR, Foley JF, Anderson MW: High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57B2/6J × BALB/cJ) mice. Carcinogenesis 1995;16:1065-1069.
25. Karasaki H, Obata M, Ogawa K, Lee G-H: Roles of the Pas1 and Par2 genes in determination of the unique intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: Differential effects on tumor multiplicity, size, and Kras2 mutations. Oncogene 1997;15:1833-1840.
26. Chen B, Johanson L, Wiest JS, Anderson MW, You M: Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens. Proc Natl Acad Sci USA 1994;91:1589-1593.
27. Malkinson AM, You M: The intronic structure of cancer-related genes regulates susceptibility to cancer. Mol Carcinog 1994;10:61-65.
28. Lin L, Festing MFW, Devereux TR, Crist KA, Christensen SC, Wang Y, Svenson K, Paigen B, Malkinson AM, You M: Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res, in press.
29. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RC: Oncogene-induced liver neoplasia in transgenic mice. Oncogene 1989;4:715-724.
30. Saitoh A, Kimura M, Takahashi R, Yokoyama M, Nomura T, Izawa M, Sekiya T, Nishimura S, Katsuki M: Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 1990;5:1195-1200.
31. Fijneman RA, Ophoff RA, Hart AAM, Demant P: Kras2 alleles, mutations, and lung tumor susceptibility in the mouse - An evaluation. Oncogene 1994;9:1417-1421.
32. Pataer A, Nishimura M, Kamoto T, Ichiuka K, Sato M, Hiai H: Genetic resistance to urethane-induced pulmonary adenomas in SMXA recombinant inbred strains. Cancer Res 1997;57:2904-2908.
33. Paterson AB: Molecular Dissection of Complex Traits. Boca Raton, CRC Press, 1998.
34. Festing MFW, Yang AL, Malkinson AM: At least four genes are associated with susceptibility to urethane-induced pulmonary adenomas in mice. Genet Res 1994;64:99-106.
35. Lavinguer A, Maltby V, Mock D, Rossart J, Paulson T, Bernstein A: High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 1989;9:3982-3991.
36. Wikenheiser KA, Whitsett JA: Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 large T antigen transgenic mice. Am J Respir Cell Mol Biol 1997;16:713-723.
37. DeMayo FJ, Finegold MJ, Hanson TN, Stanley LA, Smith B, Bullock DW: Expression of SV40 T antigen under control of rabbit uteroglobin promoter in transgenic mice. Am J Physiol 1991;261: L70-L76.
38. Sakumi K, Shiraishi A, Shimizu S, Tsuzuki T, Ishikawa T, Sekiguchi M: Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res 1997;57:2415-2418.
39. Berard J, Gaboury L, Landers M, De Repentigny Y, Houle B, Kothary R, Bradley WEC: Hyperplasia and tumours in lung, breast and other tissues in mice carrying a RAR β4-like transgene. EMBO J 1994;13:5570-5580.
40. Shafarenko M, Mahler J, Cochran C, Kisielewski A, Golding E, Wiseman R, Goodrow T: Similar incidence of K-ras mutations in lung carcinomas of FVB/N mice and FVB/N mice carrying a mutant p53 transgene. Carcinogenesis 1997;18:1423-1426.
41. Belinsky SA, Nikula KJ, Baylin SB, Issa JPJ: Increased cytosine DNA-methyltransferase activity is target cell-specific and an early event in lung cancer. Proc Natl Acad Sci USA 1996;93:4045-4050.
42. Herzog CR, Wiseman RW, You M: Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res 1994;54:4007-4010.
43. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the Ink4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
44. ARF. Cell 1997;91:649-659.
45. Fazell A, Dickinson SL, Hermiston ML, Tighe RV, Steen RG, Small CG, Stoeckli ET, Keino-Masu K, Masu M, Rayburn H, Simons J, Bronson RT, Gordon JI, Tessler-Lavigne M, Weinberg RA: Phenotype of mice lacking functional deleted in colorectal cancer (DCC) gene. Nature 1997;386:796-804.
46. Prows DR, Shertzer HG, Daly MJ, Sidman CL, Leikauf GD: Genetic analysis of ozone-induced acute lung injury in sensitive and resistant strains of mice. Nat Genet 1997;17:471-478.
47. Miller ACK, Dwyer LD, Auerbach CE, Miley FB, Dinsdale D, Malkinson AM: Strain-related differences in the pneumotoxic effects of chronically-administered butylated hydroxytoluene on protein kinase C and calpain. Toxicology 1994;90:141-159.
48. Gabathuler R, Reid G, Kolaitis G, Driscoll J, Jeffries WA: Comparison of cell lines deficient in antigen presentation reveals a function role for TAP-1 alone in antigen processing. J Exp Med 1994;180:1415-1425.
49. Nazak-Stewart MM, Mutulsky AG, Eaton DL, White E, Hornung SK, Leng Z-T, Stapleton P, Weiss NS: The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 1993;53:2313-2318.
50. Nakachi N, Imai K, Hayashi S, Watanabe J, Kawajiri K: Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991;51:5177-5180.
51. Oreffo VIC, Robinson S, You M, Wu MC, Malkinson AM: Decreased expression of adenomatous polyposis coli (Apc) and mutated in colon cancer (Mcc) genes in mouse lung neoplasia. Mol Carcinog 1998;21:37-50.
52. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould K, Luong C, Borenstein N, Dove W: Genetic identification of Mom-1, a major modifier locus affecting induced intestinal neoplasia in the mouse. Cell 1993;75:631-639.
53. Gould K, Luongo C, Moser AR, McNeley MK, Borenstein N, Shedlovsky A, Dove W, Hong K, Dietrich WF, Lander ES: Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice. Genetics 1996;144:1777-1785.
54. Heasley LE, Thaler S, Nicks M, Price B, Skorecki K, Nemenoff RA: Induction of cytosolic phospholipase A2 by oncogenic ras in human non-small cell lung cancer. J Biol Chem 1997;272:14510-14514.
55. Darvasi A: Experimental strategies for the genetic dissection of complex traits in animal models. Nat Genet 1998;18:19-24.
56. Darvasi A, Soller M: Advanced intercross lines, an experimental population for fine genetic mapping. Genetics 1995;141:1199-1207.
57. kipl, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
58. Jakowlew SB, Moody TW, You L, Mariano JM: Reduction of transforming growth factor-beta type II receptor in mouse lung carcinogenesis. Mol Carcinog 1998;22:46-56.
59. Devereux TR, Anna CH, Patel AC, White CM, Festing MFW, You M: Smad4 (homolog of human DPC4) and Smad2 (homolog of human JV18-1). Candidates for murine lung tumor resistance and suppressor genes. Carcinogenesis 1997;18:1751-1755.
60. Oomen LCJM, Demant P, Hart AAM, Emmelot P: Multiple genes in the H-2 complex affect differently the number and growth rate of transplacentally induced lung tumors in mice. Int J Cancer 1983;31:447-454.
61. Droms KA, Fernandez CA, Thaete LG, Malkinson AM: Effects of adrenalectomy and corticosterone administration on mouse lung tumor susceptibility and histogenesis. J Natl Cancer Inst 1988;80:365-369.
62. Wattenberg LW, Estensen RD: Chemopreventative effects of myo-inositol and dexamethasone on benzo(a)pyrene and 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res 1996;56:5132-5135.
63. Thaete LG, Nesbitt MN, Malkinson AM: Genetic analysis of the distribution of corticosterone-containing cells in the mouse adrenal cortex. Proc Soc Exp Biol Med 1990;194:97-102.
64. Wu M-C, Sundaresan M, Sundaresan V, Rabbitts P: Genome wide search for genetic damage in p53 transgenic mouse lung tumours reveals consistent loss of chromosome 4. Eur J Cancer 1997;33:1677-1684.
65. Barard J, Laboune F, Mukuna M, Masse S, Kothary R, Bradley WEC: Lung tumors in mice expressing an antisense RARβ2 transgene. FASEB J 1996;10:1091-1097.
66. Moon RC, Rao KUN, Detrisac CJ, Kelloff GJ: Animal models for chemoprevention of respiratory cancers. J Natl Cancer Inst Monogr 1992;13:45-50.
67. Jetten AM, Nervi C, Vollberg TM: Control of differentiation in tracheobronchial and epidermal epithelial cells: Role of retinoids. J Natl Cancer Inst Monogr 1992;13:93-100.
68. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
69. Manenti G, Gariboldi M, Elango R, Fiorino A, De Gregorio L, Falvella FS, Hunter K, Housman D, Pierotti MA, Dragani TA: Genetic mapping of a pulmonary adenoma resistance locus (Par 1) in mouse. Nat Genet 1996;12:455-457.
70. Gariboldi M, Vivat V, De Gregorio L, Manenti G, Chiariello E, Falvella FS, Pierotti MA, Dragani TA: Analysis of the retinoic acid receptor a gene as a candidate for the pulmonary adenoma resistance 1 gene. Mol Carcinog 1998;21:13-16.
71. Jacoby RF, Hohman C, Marshall DJ, Frick TJ, Schlack S, Broda M, Smutko J, Elliott RW: Genetic analysis of colon cancer susceptibility in mice. Genomics 1994;22:381-387.
72. Manenti G, Falvella FS, Gariboldi M, Dragani TA, Pierotti MA: Different susceptibility to lung tumorigenesis in mice with an identical Kras intron 2. Genomics 1995;29:438-444.
73. Manenti G, Gariboldi M, Fiorino A, Zanesi N, Pierotti MA, Dragani TA: Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res 1997;57:4164-4166.
74. Malkinson AM: Prevention of BHT-induced lung damage in mice by cedar terpene administration. Toxicol Appl Pharmacol 1979;49:551-560.
75. Witschi H, Williamson D, Lock S: Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene. J Natl Cancer Inst 1977;58:301-305.
76. Malkinson AM, Koski KM, Evans WA, Festing MFW: Exposure to butylated hydroxytoluene is necessary for lung tumor development in BALB mice treated with low doses of 3-methylcholanthrene. Cancer Res 1997;57:2832-2834.
77. Gazdar AF, Linnoila RI: The pathology of lung cancer: Changing concepts and newer diagnostic techniques. Semin Oncol 1988;15:215-225.
78. Thaete LG, Gunning WT, Stoner GD, Malkinson AM: Cellular derivation of lung tumors in sensitive and resistant strains of mice: Results at twenty-eight and fifty-six weeks after urethan treatment. J Natl Cancer Inst 1987;78:743-749.
79. Kauffman SL: Histogenesis of the papillary Clara cell adenoma. Am J Pathol 1981;103:174-180.
80. Gunning WT, Castonguay A, Goldblatt PJ, Stoner GD: Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens. Toxicol Pathol 1991;19:168-175.
81. Branstetter DG, Stoner GD, Budd C, Conran PB, Goldblatt PJ: Effect of gestational development on lung tumor size and morphology in the mouse. Cancer Res 1988;48:379-386.
82. Thaete LG, Nesbitt MN, Malkinson AM: Lung tumor structure among inbred strains of mice: The pulmonary adenoma histologic type (pah) genes. Cancer Lett 1991;61:15-20.
83. Grady HG, Stewart HL: Histogenesis of induced pulmonary tumors in strain A mice. Am J Pathol 1940;16:417-432.
84. Rehm S, Ward JM, Ten Have-Opbroek AAW, Anderson LM, Singh G, Katyal SL, Rice JM: Mouse papillary lung tumors transplacentally induced by N-nitrosoethylurea: Evidence for alveolar type II cell origin by comparative light microscopic, ultrastructural, and immunohistochemical studies. Cancer Res 1988;48:148-160.
85. Oomen LCJM, Ten Have-Opbroeck AAW, Hageman PC, Oodshoorn M, Egberts J, Vandervalk MA, Calafat J, Demant P: Fetal mouse alveolar type II cells in culture express several type II cell characteristics found in vivo together with major histocompatibility antigens. Am J Respir Cell Mol Biol 1990;3:325-339.
86. Forkert PG, Parkinson A, Thaete LG, Malkinson AM: Resistance of murine lung tumors to xenobiotic-induced cytotoxicity. Cancer Res 1993;53:393-401.
87. Glasser SW, Korfhagen TR, Wert SE, Whitsett JA: Transgenic models for study of pulmonary development and disease. Am J Physiol 1994;267:L489-L497.
88. Reznik-Schuller H: Ultrastructural alterations of nonciliated cells after nitrosamine carcinogenesis and their significance for pulmonary carcinogenesis. Am J Pathol 1976;85:549-554.
89. Malkinson AM: Genetic studies on lung tumor susceptibility and histogenesis in mice. Environ Health Perspect 1991;93:149-159.
90. Festing MFW, Lin L, Devereux TR, Gao F, Yang A, Anna CH, White CM, Malkinson AM, You M: At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J × BALB/c mice. Genomics, submitted.
91. Gariboldi M, Manenti G, Canzian F, Falvella FS, Radice MT, Pierotti MA, Della Porta G, Binelli G, Dragani TA: A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat Genet 1993;3:132-136.
92. Devereux TR, Wiseman RW, Kaplan N, Garren S, Foley JF, White CM, Anna C, Watson MA, Patel A, Jarchow S, Maronpot RR, Anderson MW: Assignment of a locus for mouse lung tumor susceptibility to proximal chromosome 19. Mamm Genome 1994;5:749-755.
93. Silver LM, Nadeau JH: Mamm Genome 1997;(suppl):S1-S388.
94. Peters J, Searle AG: Linkage and synteny homologies in mouse and man; in Lyon MF, Rastan S, Brown SDM (eds): Genetic Variants and Strains of the Laboratory Mouse. New York, Oxford Press, 1996, pp 1256-1311.
95. Testa JR: Chromosome alterations in human lung cancer; in Pass HI, Mitchell JB, Johnson DH, Turrisi AT (eds): Lung Cancer: Principles and Practice. Philadelphia, Lippincott-Raven, 1996, pp 55-72.